Skip to content
EN
brief us →

Exactech, Inc.: recalls, TPG ownership and bankruptcy

Exactech, Inc.: participants and roles

Participants and documented roles around Exactech: founders and family vehicles, directors and officers, shareholders, the TPG funds and Osteon holding companies, subsidiaries, suppliers, lenders, advisers, the buyer and its owners, the trusts and the courts, regulators and plaintiffs named in the record.

published
16 oct 2026
records as of
16 oct 2026
entities
167
sources
121
cite entities.csv
Independent director; special committee memberIndependent director; special committee memberIndependent director; special committee memberAcquirer of the product lines, product data, operations and staff in the restructuringMember of the LLCMember of the LLCProvider of transition services after the Brighton Partners purchaseDirectorManaging directorBoard member with signing authorityDirectorDirectorPlaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)DirectorDirectorManaging directorManaging directorDirectorDirectorDirector (+1)President, chief executive officer and directorDirector (+3)DirectorCo-executive chairman, then executive chairman; directorAdviser (former Biomet chief executive) taking part in the 2017 approachSenior adviser and consultantSenior adviser under an agreement of 29 June 2015 (amended 6 March 2018)DirectorAcquirer of 81% (31 July 2017); absorbed the company by merger on 31 December 2017Shareholder: 800,197 shares (5.5%)Chief financial officer and executive vice presidentTreasurerConsultant; field operations adviser in TPG Capital's operations groupCo-founder; presidentListed officer (register index; no title or dates shown)Co-founder; company secretary since inception; treasurer and director until March 1996 (+3)OfficerRollover investor: 75,400 shares exchanged for 3,713,450 Class A Parent sharesCo-owner with William Petty (company wholly owned by the couple)Limited partner with William Petty and their childrenSupplier of raw materials, equipment and licences (related party)Co-counsel in the suit against TPGCounsel to the official committee of unsecured creditorsOwner of the consulting companyBeneficial owner of 24%Director (+2)Senior scientist and associate attending orthopaedic surgeon (biomechanical engineering)DirectorDirectorManaging directorCounsel to the trustee and wind-down officerChief financial officer (+1)Chief financial officerChief quality and regulatory clinical officerDirectorDirectorPrincipalDirectorSenior adviserShareholder: 751,750 shares (5.2%)Director of sales, Northeast regionDirectorListed officer (register index; no title or dates shown)President and director (+4)Vice chairmanChief executive officerDirectorDirectorRollover investor: 50,000 shares exchanged for 2,462,500 Class A Parent sharesDirectorDirectorManaging director; co-head of the operations teamManaging memberWind-down officer; officer in the 2026 Florida annual reportTrusteeVice president, legal; later general counsel, senior vice president and secretary (+1)SecretaryRollover investor: 18,052 Exactech sharesStalking-horse bidder for substantially all assetsNotice address (c/o the trust company in Singapore)DirectorLicensee paying royalties on a bipolar hip prosthesis510(k) applicant with Advita Ortho as correspondent (K260583) (+1)Parent (subsidiary listed in Exhibit 21.1)Parent (acquired its independent Australian distributor) (+1)Shareholder (about 5% reported in June 2019)Distributor of its products under a non-exclusive agreementParent (100%); buyer of goods and services from itAcquirer of all shares for $5,500,000Client: investment bankerParent (subsidiary listed in Exhibit 21.1) (+1)Seller under the stalking-horse asset purchase agreementParent (subsidiary listed in Exhibit 21.1) (+2)Parent group company (2024 group chart)Parent (subsidiary listed in Exhibit 21.1) (+2)Parent (subsidiary listed in Exhibit 21.1) (+1)Borrower under the first-lien credit agreement, for which the company became agentBorrower under the first-lien credit agreement, for which the bank was agentClient: outside counsel authorised to sign the 2010 deferred prosecution agreementLicensee paying royalties on the Optetrak knee systemSupplier of implants (HSS described as its largest domestic customer)Parent (subsidiary listed in Exhibit 21.1) (+1)Parent (subsidiary listed in Exhibit 21.1) (+1)Direct parent (as recorded in the LEI register) (+1)Plaintiff in adversary proceeding 1:24-ap-50297 (dismissed with prejudice on 5 November 2025)Holder of membership interests; exclusive distributor under the agreement of 24 August 2023 (+1)Client: financial adviser on the merger (engagement letter of 13 October 2017)Borrower under a $150 million revolving credit facility led by the bankParent (subsidiary listed in Exhibit 21.1) (+1)Parent group company (2024 group chart)Surviving corporation of the merger with Osteon Merger Sub, Inc.Listed issuer (ticker EXAC)Holder of 24.55%Target company under the merger agreement of 22 October 2017 (price $49.25 per share after the amendment)Parent group company (2024 group chart)Client: financial adviserClient: legal counsel (restructuring and Chapter 11)Distributor of its products under a non-exclusive agreementParent (subsidiary listed in Exhibit 21.1)Parent (subsidiary listed in Exhibit 21.1)Distributor of its products under an exclusive agreementAdverse party on alter-ego and veil-piercing claims (bankruptcy court ruling of 20 May 2025)Party to the confidentiality agreement of 7 August 2017Parent (subsidiary listed in Exhibit 21.1) (+2)Special committee's independent counselParent (100%)Client: co-counselRelator (whistle-blower plaintiff) in qui tam No. 7:18-cv-1010 (N.D. Ala.) (+1)Chair of the boardSenior adviserChief financial officerExecutive officer; signed the Form D as vice presidentShareholder: 707,500 shares (5.5%)Relator (whistle-blower plaintiff) in qui tam No. 7:18-cv-1010 (N.D. Ala.) (+1)Shareholder: 798,294 shares (6.2%) (+1)DirectorMember of the audit and compliance committeeDirectorPrincipalAcquirer and parent groupDirector and audit committee memberDirector and audit committee memberOwner (funds managed by affiliates)Member of the ownership group acquiring substantially all operations and assetsWind-down officer (named in the confirmation order)Commercial GUC trustee (named in the confirmation order)Senior vice president, business developmentRepresentative of TPG at the first meeting with Exactech (1 May 2017)Consultant to TPG (per the complaint)Lead applicant in class action NSD 1224 of 2024Lead applicant in class action NSD 1224 of 2024Chief financial officerSupplier of polyethylene vacuum bags (per the complaint)Managing directorDirectorDirectorParty whose consent was required to transfer Exactech's JointMedica interestCo-venturer whose consent was required to transfer Exactech's interestDirector (+1)PresidentDirectorDirectorPlaintiff in a 1995 patent-infringement action (dismissed without prejudice as to Exactech on 28 July 1995)DirectorCounsel in the Chapter 11 caseCounsel in the Chapter 11 caseCounsel to the TPG defendants in the MDL (+1)DirectorManaging directorIndependent directorVice president; signed the articles of mergerExecutive officerVice president; signed for TPG Partners VII, L.P. through its general-partner chainCo-founderMember of the TPG health-care teamAuthorised personAssistant secretary (+1)DirectorChief operating officerIndependent registered public accounting firmDirectorPrincipal memberShareholder: 142,370 sharesRollover investor: 47,650 Exactech sharesCounsel receiving copies of the purchaser's noticesDirectorBeneficial owner of 2.8%Co-founder; vice president, later executive vice president, research and development (+7)Owner with his wife and childrenOwner of the general partner (Millerworks, Inc.); his family holds all partnership interestsShareholder: 411,212 shares (3.2%)PresidentDirectorDirectorDirectorIndirect parent (100%) after the mergerAgreed parent (100%) after the mergerParent (100%) of the merger subsidiaryParent (100%)Person with significant control (more than 75%)Parent (100%)Seller under the stalking-horse asset purchase agreementSole shareholder (100%) (+2)Relator in qui tam No. 21-cv-3325-SAG (D. Md.)Relator in claims against TPG Capital, L.P. (dismissed voluntarily without prejudice on 23 April 2026)Treasurer (+3)Rollover investor: 82,000 Exactech sharesDirectorIndependent director; special committee memberIndependent director; special committee memberIndependent director; special committee memberGeneral partnerShareholder: 3,517,498 shares (27.3%) (+1)Rollover investor: 2,300,000 Exactech shares exchanged for 130,757,376 Class B Parent sharesSettlement trustee (+1)Authorised person; signed the asset purchase agreementFounder and managing director (as described by GLAS)Senior vice president, extremitiesEmployee (from 2003); senior vice president, extremities, from July 2021Rollover investor: 4,458 Exactech sharesBoard member with signing authorityDirector (nominated in 2010)Chief human resources officerChief executive officer and directorDirectorMember of the audit and compliance committeeDirectorPartner and head of operations, TPG CapitalDirectorPresident and chief operating officer; director (+1)DirectorDirectorManaging partner of TPG Capital North America (+1)Sponsor: direct or indirect equityholder, manager, consultant and lender (restructuring support agreement definition) (+1)Majority shareholder (88%) and Majority Lead Investor under the shareholders agreementOwner (funds managed by affiliates)Member of the ownership group acquiring substantially all operations and assetsCo-founderOwner (funds managed by affiliates)Same business address (100 West Putnam Avenue, Greenwich)Same business address (100 West Putnam Avenue, Greenwich)Member of the ownership group acquiring substantially all operations and assetsRollover investor: 6,345 Exactech sharesTPG principal attending board and audit committee meetingsPrincipal, TPG CapitalSenior vice president (general manager, biologics and spine division, in 2010; strategic initiatives by 2018)DirectorRollover investor: 25,279 Exactech sharesDirectorAcquirer of all common stock through its affiliated fund and holding companies (Exactech's closing announcement)General partnerGeneral partnerManager under the Management Services Agreement (annual fee of $1 million)Sponsor: Parent described as an affiliate of TPG Capital, L.P.Sponsor of the fund (one of TPG, Inc.'s funds)Fund that jointly owned Parent and committed up to $737,057,000 of equity (+1)Holder of 95% and funderPlaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Successor to the debtors' personal-injury and wrongful-death liabilities and estate causes of action under the planPlaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)Relator (whistle-blower plaintiff) in qui tam No. 7:18-cv-1010 (N.D. Ala.) (+1)Independent directorDirectorSpouseJoint owner with Betty Petty of 4.6%FatherCo-founder; chairman of the board since inception (+10)Executive chairman (2014–2018); co-executive chairman with Jeffrey BinderOfficer and registered agentDirectorRollover investor: 102,400 shares exchanged for 5,821,546 Class B Parent sharesPresident and registered agent (+1)Limited partner with Betty Petty and their childrenListed with the title 'Other' in the 2026 Florida annual reportSeller under the stalking-horse asset purchase agreementGuarantor of the first-lien loansMember of the TPG health-care teamForeign representative in the Australian recognition proceeding (+1)Managing director (senior managing director)Millerworks,LimitedPartnershipMillerworks, Limited PartnershipExactOrtho, Inc.ExactOrtho, Inc.ExactechInternational,Inc. (Barbados)Exactech International, Inc. (Barbados)GAMCO Investors,Inc.GAMCO Investors, Inc.Timothy J. SeeseTimothy J. SeeseAlbert H. BursteinAlbert H. BursteinHospital forSpecial SurgeryHospital for Special SurgeryAH Burstein, Ph.D., ConsultingEngineer, Inc.AH Burstein, Ph. D., Consulting Engineer, Inc.Stuart KleopferStuart KleopferGreywolf CapitalManagement LPGreywolf Capital Management LPCraig JamesCraig JamesAlan D. HalperinAlan D. HalperinExactechCommercial GUCLiquidating TrustExactech Commercial GUC Liquidating TrustDave RichardsDave RichardsExactech Taiwan(Taiwan), Ltd.Exactech Taiwan (Taiwan), Ltd.Prima Investments,Inc.Prima Investments, Inc.Prima Investments,LimitedPartnershipPrima Investments, Limited PartnershipBetty PettyA11Betty PettyA11: Defendant in a 2018 shareholder suit and in Florida product-liability suits closed after the bankruptcy; allegations not adjudicatedBrighton Partners,Inc.Brighton Partners, Inc.JointMedicaInvestmentHoldings, L.P.JointMedica Investment Holdings, L.P.Donna EdwardsDonna EdwardsJointMedicaLimitedJointMedica LimitedTony CollinsTony CollinsMilbank LLPMilbank LLPStellex CapitalManagement LLCStellex Capital Management LLCCatherine DeMarcoCatherine DeMarcoPaul HaydockPaul HaydockLuigi FerrariLuigi FerrariAdvita HoldingsLLCAdvita Holdings LLCBioGendTherapeutics Co.,Ltd.BioGend Therapeutics Co., Ltd.Karen GolzKaren GolzKendall GarrisonA14Kendall GarrisonA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedJohn SchillingA14John SchillingA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedBrooks WallaceBrooks WallaceOsteon Holdings,L.P.Osteon Holdings, L.P.Joel C. PhillipsJoel C. PhillipsBruce ThompsonBruce ThompsonExactech U.S.,Inc.Exactech U.S., Inc.Robert FarleyRobert FarleyChris RocheChris RocheAdvita Ortho, LLCAdvita Ortho, LLCClara AndersonClara AndersonDave DemskiDave DemskiStrategic ValuePartners, LLCStrategic Value Partners, LLCAdvita Holdings IILLCAdvita Holdings II LLCJeffrey BinderA14Jeffrey BinderA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedOsteon Holdings,Inc.A15Osteon Holdings, Inc.A15: Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)David W. PettyA10David W. PettyA10: Defendant in the Settlement Trust's pending fiduciary-duty suit and earlier shareholder and product suits; allegations not adjudicatedWilliam PettyA10William PettyA10: Defendant in the Settlement Trust's pending fiduciary-duty suit and earlier shareholder and product suits; allegations not adjudicatedGary J. MillerA12Gary J. MillerA12: Co-defendant in Florida product-liability suits; moved to dismiss; cases closed after the 2024 bankruptcyExactech, Inc.A1 · A2 · A3 · A4 · A5 · A6 · A7Exactech, Inc.A1: 2010 deferred prosecution agreement on an anti-kickback conspiracy charge; complaint to be dismissed on 12 months of compliance · A2: Voluntary Class II device recalls, including the 2021–2024 polyethylene recalls over defective packaging · A3: FDA warning letters of January 2024 (Gainesville) and December 2025 (Sarasota, addressed to 'Exactech, Inc. dba Advita Ortho') · A4: Defendant in product-liability litigation (MDL 3044 and the Florida master case); claims passed to the Settlement Trust under the 2025 plan · A5: Respondent in an Australian class action settled for about A$8.7 million without admission of liability (approved 13 November 2025) · A6: Agreed in 2025 to pay $8 million to settle False Claims Act allegations, with no determination of liability; declined a Corporate Integrity Agreement · A7: Chapter 11 debtor (D. Del. No. 24-12441); plan confirmed 17 September 2025 with the sale of the businessExactech UKLimitedExactech UK LimitedDarin JohnsonDarin JohnsonEI Bidco, LLCEI Bidco, LLCExactech KKExactech KKJessica LivingstonJessica LivingstonOsteon Merger Sub,Inc.Osteon Merger Sub, Inc.Matthew RichardsMatthew RichardsWatiga Trust LtdWatiga Trust LtdGlobal Loan AgencyServices GroupGlobal Loan Agency Services GroupTodd SisitskyA14Todd SisitskyA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedTPG Inc.A13TPG Inc.A13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingExactechSettlement TrustExactech Settlement TrustTPG VII OsteonHoldings, L.P.A13TPG VII Osteon Holdings, L.P.A13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingTPG Partners VII,L.P.A13TPG Partners VII, L.P.A13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingOsteonIntermediateHoldings II, Inc.A15Osteon Intermediate Holdings II, Inc.A15: Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)Timothy PohlTimothy PohlKerem BolukbasiKerem BolukbasiNathan BeckleyNathan BeckleyRichard EdmundAndrews Jr.Richard Edmund Andrews Jr.ExactechInternationalOperation AGExactech International Operation AGJeffrey FiggJeffrey FiggJoint MedicalJoint MedicalBrown Rudnick LLPBrown Rudnick LLPOfficial Committeeof UnsecuredCreditors ofExactech, Inc.Official Committee of Unsecured Creditors of Exactech, Inc.John LinA14John LinA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedKirkland & EllisLLPKirkland & Ellis LLPMichael TepattiA14Michael TepattiA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedPasquale PetreraPasquale PetreraExactech ItaliaS.p.A.Exactech Italia S.p.A.M. ElizabethAbramsM. Elizabeth AbramsXpandOrtho, Inc.A15XpandOrtho, Inc.A15: Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)Nicolas HohlNicolas HohlExactech (UK) 2LimitedExactech (UK) 2 LimitedEric AstoinEric AstoinAndrew O'HareAndrew O'HareExactech KoreaJusik HoesaExactech Korea Jusik HoesaJ.P. Morgan ChaseBankJ.P. Morgan Chase BankMichael LaGattaMichael LaGattaDimensional FundAdvisors LPDimensional Fund Advisors LPOsteonIntermediateHoldings I, Inc.A15Osteon Intermediate Holdings I, Inc.A15: Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)Daniel P. HannDaniel P. HannEllen K. ReismanEllen K. ReismanMiller FamilyHoldings, Inc.Miller Family Holdings, Inc.Miller FamilyHoldings, LLCMiller Family Holdings, LLCExactech Iberica,S.L.Exactech Iberica, S.L.Jesse YorkJesse YorkRiveron RTS, LLCRiveron RTS, LLCExactech FranceSASExactech France SASRTI Surgical, Inc.RTI Surgical, Inc.Gwen BinghamGwen BinghamGLAS Trust CompanyLLCGLAS Trust Company LLCGreenberg TraurigP.A.Greenberg Traurig P.A.Matthew DundonMatthew DundonHillman SupplyCompany, Inc.A9Hillman Supply Company, Inc.A9: Co-defendant, as alleged packaging supplier, in Florida product-liability suits; filed answers and defences; cases closed after the 2024 bankruptcyFern S. WattsFern S. WattsThe Arbitrage FundThe Arbitrage FundBennett YasskinA14Bennett YasskinA14: Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicatedJames G. BinchJames G. BinchExactechInternationalCorporationExactech International CorporationManuel FuentesManuel FuentesNasdaqNasdaqMcGladrey &Pullen, LLPMcGladrey & Pullen, LLPYoung ConawayStargatt & Taylor,LLPYoung Conaway Stargatt & Taylor, LLPR. Wynn Kearney,Jr.R. Wynn Kearney, Jr.CenterviewPartnersCenterview PartnersBiomatlante SARLBiomatlante SARLWhite & Case LLPWhite & Case LLPCole Schotz P.C.Cole Schotz P.C.Paul E. MettsPaul E. MettsWilliam B.LocanderWilliam B. LocanderW. Andrew Krusen,Jr.W. Andrew Krusen, Jr.TPG VIIManagement, LLCA13TPG VII Management, LLCA13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingRichard C. SmithRichard C. SmithSimon HarroldSimon HarroldExactech AustraliaPty LtdA5Exactech Australia Pty LtdA5: Respondent in an Australian class action settled for about A$8.7 million without admission of liability (approved 13 November 2025)J.P. MorganSecurities LLCJ.P. Morgan Securities LLCBlackRock, Inc.BlackRock, Inc.Exactech Portugal,LDAExactech Portugal, LDAFMR LLCFMR LLCDouglas DonofrioA8Douglas DonofrioA8: Pleaded guilty in 2010 to conspiring to violate the anti-kickback statute; sentence not in the recordRick WrightRick WrightDiana NoleDiana NoleTPG Genpar VII,L.P.TPG Genpar VII, L.P.Dundon AdvisersLLCDundon Advisers LLCTPG Global, LLCTPG Global, LLCTPG Holdings IISub, LPA13TPG Holdings II Sub, LPA13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingTPG Operations,LLCA13TPG Operations, LLCA13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingDavid Timm BackhußDavid Timm BackhußExactech EÖG GmbHExactech EÖG GmbHExactechDeutschland GmbHExactech Deutschland GmbHElliot NessCintronElliot Ness CintronGoldman Sachs BankUSAGoldman Sachs Bank USAExactech Medical(Shanghai), Ltd.Exactech Medical (Shanghai), Ltd.Ropes & Gray LLPRopes & Gray LLPSteve C de BacaSteve C de BacaAndrew EkdahlAndrew EkdahlAccumed, Inc.Accumed, Inc.TPG Genpar VIIAdvisors, LLCTPG Genpar VII Advisors, LLCAltiva CorporationAltiva CorporationAdam FlissAdam FlissSteve SzaboSteve SzaboTPG Capital – FO,LLCA13TPG Capital – FO, LLCA13: Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoingMichael CraderMichael CraderOrthopedic DesignsNorth America,Inc.Orthopedic Designs North America, Inc.Alexander KohtzAlexander KohtzStéphane LavalléeStéphane LavalléeBlue Ortho SASBlue Ortho SASLaurent MouillacLaurent MouillacAnthony BoyerAnthony BoyerJorge LopesJorge LopesMonica RognoniMonica RognoniRebecca YoungRebecca YoungAurelio SahagunAurelio SahagunJames StiehlJames StiehlBiomet, Inc.Biomet, Inc.Tecres S.p.A.Tecres S.p.A.

Solid line: documented. Amber dashed: reported. Grey dotted: hypothesis. One arrow: the relationship as stated; two arrows: reciprocal; no arrow: symmetric. A path between two parties does not transfer an allegation from one to the other.

every party and relationship in full, as text ↓

Information markers
  • A1 · 2010 deferred prosecution agreement on an anti-kickback conspiracy charge; complaint to be dismissed on 12 months of compliance — Exactech, Inc.
  • A2 · Voluntary Class II device recalls, including the 2021–2024 polyethylene recalls over defective packaging — Exactech, Inc.
  • A3 · FDA warning letters of January 2024 (Gainesville) and December 2025 (Sarasota, addressed to 'Exactech, Inc. dba Advita Ortho') — Exactech, Inc.
  • A4 · Defendant in product-liability litigation (MDL 3044 and the Florida master case); claims passed to the Settlement Trust under the 2025 plan — Exactech, Inc.
  • A5 · Respondent in an Australian class action settled for about A$8.7 million without admission of liability (approved 13 November 2025) — Exactech Australia Pty Ltd
  • A6 · Agreed in 2025 to pay $8 million to settle False Claims Act allegations, with no determination of liability; declined a Corporate Integrity Agreement — Exactech, Inc.
  • A7 · Chapter 11 debtor (D. Del. No. 24-12441); plan confirmed 17 September 2025 with the sale of the business — Exactech, Inc.
  • A10 · Defendant in the Settlement Trust's pending fiduciary-duty suit and earlier shareholder and product suits; allegations not adjudicated — David W. Petty
  • A12 · Co-defendant in Florida product-liability suits; moved to dismiss; cases closed after the 2024 bankruptcy — Gary J. Miller
  • A11 · Defendant in a 2018 shareholder suit and in Florida product-liability suits closed after the bankruptcy; allegations not adjudicated — Betty Petty
  • A8 · Pleaded guilty in 2010 to conspiring to violate the anti-kickback statute; sentence not in the record — Douglas Donofrio
  • A13 · Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing — TPG Capital – FO, LLC
  • A14 · Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated — John Lin
  • A15 · Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441) — Osteon Intermediate Holdings I, Inc.
  • A9 · Co-defendant, as alleged packaging supplier, in Florida product-liability suits; filed answers and defences; cases closed after the 2024 bankruptcy — Hillman Supply Company, Inc.

Markers apply only to the named participant. They do not transfer allegations to connected parties.

Participants 167

Subject

Leadership

Group companies

Counterparties

Historical

Other

Relationship register 369

chronology

  1. Exactech, Inc. is incorporated in Florida, founded by William Petty, Gary J. Miller and Betty Petty c-identity c-founding
  2. A Pinellas County suit alleges deterioration of Exactech hip components c-early-suits
  3. Exactech lists on Nasdaq in its initial public offering c-founding c-pre-ipo
  4. A Barbados company named Exactech International, Inc. is incorporated c-barbados
  5. Exactech buys the insider-owned supplier Brighton Partners for $5,500,000 c-brighton
  6. Deferred prosecution agreement over an anti-kickback conspiracy charge; a regional sales director pleads guilty c-dpa-2010 c-donofrio
  7. Exactech buys Blue Ortho, developer of the ExactechGPS system c-blueortho
  8. Exactech buys its independent Australian distributor c-portfolio-2016
  9. Daniel Hann and Jeffrey Binder meet the Pettys in Gainesville to discuss a TPG investment c-deal-background
  10. Merger agreement with Osteon Merger Sub, an affiliate of TPG Capital c-merger-agreement
  11. Merger price raised from $42.00 to $49.25 per share c-merger-agreement
  12. First shareholder class action over the merger filed in the Northern District of Florida c-deal-suits
  13. Merger closes; Exactech becomes an indirect wholly owned subsidiary of Osteon Holdings, Inc. c-closing c-chain-petition
  14. Whistle-blowers file a qui tam suit over Exactech knee implants in Alabama c-quitam-alabama
  15. The Alabama qui tam complaint is unsealed after the United States declines to intervene c-quitam-alabama
  16. Darin Johnson becomes president and chief executive; William Petty steps back c-executives
  17. Florida appeal court reverses the denial of class certification in The Arbitrage Fund's suit c-arbitrage
  18. Recall of Connexion GXL hip liners begins c-recall-records c-recalls-overview
  19. Recall of knee and ankle inserts packaged in bags without the oxygen-barrier layer c-recall-records
  20. Knee and ankle recall expanded to all devices in defective bags regardless of shelf life c-fda-sc-2023
  21. Jeffrey Binder becomes chief executive c-executives
  22. Hip recall extended to all GXL liners c-recall-records
  23. Federal cases centralised as MDL No. 3044 in the Eastern District of New York c-mdl
  24. FDA safety communication on Exactech knee, ankle and hip devices in defective packaging c-fda-sc-2023
  25. Sidecar term loans from TPG VII Osteon Holdings c-sponsor-loans
  26. FDA safety communication on the Equinoxe shoulder system c-fda-sc-shoulder
  27. FDA warning letter after the September 2023 Gainesville inspection c-warning-2024
  28. Recall of Equinoxe shoulder liners and glenoids begins c-recall-records c-fda-sc-shoulder
  29. MDL court dismisses TPG Inc. and the Osteon companies from the personal-injury actions c-mdl-tpg-dismissal
  30. Class action filed in the Federal Court of Australia c-australia-class
  31. Exactech and four affiliates file for Chapter 11 in Delaware; stalking-horse agreement with EI Bidco c-petition c-apa c-adhoc-rsa
  32. Bankruptcy court approves bidding procedures c-bidding
  33. Exactech and its lenders sue the JointMedica parties c-jointmedica
  34. Alabama relators and the United States seek a ruling that Exactech's debt is not dischargeable c-dischargeability
  35. Bankruptcy judge rules that Exactech and TPG share no common interest on alter-ego claims c-letter-ruling
  36. Exactech refuses a ten-year Corporate Integrity Agreement c-fca-settlement
  37. Confirmation hearing adjourned; Exactech says it is walking away from protecting TPG c-tpg-release
  38. Deed of settlement in the Australian class action c-australia-class
  39. Justice Department announces the $8 million False Claims Act settlement c-fca-settlement
  40. Fifth Amended Plan confirmed: sale to the SVP-led group and creation of the Exactech Settlement Trust c-confirmation
  41. Advita Ortho launches with Exactech's product lines c-advita-launch
  42. JointMedica adversary proceeding dismissed with prejudice c-jointmedica
  43. Federal Court of Australia approves the class-action settlement c-australia-settlement
  44. FDA warning letter to 'Exactech, Inc. dba Advita Ortho' after the Sarasota inspection c-warning-2025
  45. Settlement Trust sues TPG, its staff and advisers and William and David Petty in Delaware c-trust-suit
  46. Maryland relator dismisses the claims against TPG Capital without prejudice c-quitam-maryland
  47. The Alabama qui tam case is terminated on the docket c-quitam-alabama

cite this dossier

DossierTwist, “Exactech, Inc.: recalls, TPG ownership and bankruptcy”, dt.017, 16 October 2026, https://dossiertwist.com/dossiers/exactech/

Free to read, cite and republish with credit under CC BY 4.0: credit “DossierTwist” and link to the dossier.

Data: JSON, CSV and the network graph.

share

We listen to all sides: responses are shown next to the claims they answer. To send a correction or a reply, write to dossiertwist@proton.me.